Comparison of chemoradiotherapy and gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer: an integrated analysis of two randomized phase II trials (JCOG2408A)

Yusuke Sano, Riku Kajikawa, Junki Mizusawa, Tatsuya Ioka, Masato Ozaka, Satoaki Nakamura, Yoshinori Ito, Junji Furuse, Satoshi Kobayashi, Haruhiko Fukuda, Takuji Okusaka, Masafumi Ikeda, Haruo Miwa, Naoki Sasahira, Fumio Nagashima, Kazuyoshi Ohkawa, Kentaro Yamazaki, Masashi Kanai, Taro Yamashita, Kazuo Hara, Yukiko Takayama, Yoshito Komatsu, Nao Fujimori, Naoki Hama, Ken Kamata, Terumasa Hisano, Satoshi Shimizu, Kazutoshi Tobimatsu, Shin Maeda, Makoto Ueno

Open source

DOI: 10.1186/s12885-026-15699-8
Published: 2026-02-10
Container: BMC Cancer
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12885-026-15699-8,
  title = {Comparison of chemoradiotherapy and gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer: an integrated analysis of two randomized phase II trials (JCOG2408A)},
  author = {Yusuke Sano and Riku Kajikawa and Junki Mizusawa and Tatsuya Ioka and Masato Ozaka and Satoaki Nakamura and Yoshinori Ito and Junji Furuse and Satoshi Kobayashi and Haruhiko Fukuda and Takuji Okusaka and Masafumi Ikeda and Haruo Miwa and Naoki Sasahira and Fumio Nagashima and Kazuyoshi Ohkawa and Kentaro Yamazaki and Masashi Kanai and Taro Yamashita and Kazuo Hara and Yukiko Takayama and Yoshito Komatsu and Nao Fujimori and Naoki Hama and Ken Kamata and Terumasa Hisano and Satoshi Shimizu and Kazutoshi Tobimatsu and Shin Maeda and Makoto Ueno},
  year = {2026},
  journal = {BMC Cancer},
  doi = {10.1186/s12885-026-15699-8},
  url = {https://doi.org/10.1186/s12885-026-15699-8}
}

RIS

TY  - JOUR
TI  - Comparison of chemoradiotherapy and gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer: an integrated analysis of two randomized phase II trials (JCOG2408A)
AU  - Yusuke Sano
AU  - Riku Kajikawa
AU  - Junki Mizusawa
AU  - Tatsuya Ioka
AU  - Masato Ozaka
AU  - Satoaki Nakamura
AU  - Yoshinori Ito
AU  - Junji Furuse
AU  - Satoshi Kobayashi
AU  - Haruhiko Fukuda
AU  - Takuji Okusaka
AU  - Masafumi Ikeda
AU  - Haruo Miwa
AU  - Naoki Sasahira
AU  - Fumio Nagashima
AU  - Kazuyoshi Ohkawa
AU  - Kentaro Yamazaki
AU  - Masashi Kanai
AU  - Taro Yamashita
AU  - Kazuo Hara
AU  - Yukiko Takayama
AU  - Yoshito Komatsu
AU  - Nao Fujimori
AU  - Naoki Hama
AU  - Ken Kamata
AU  - Terumasa Hisano
AU  - Satoshi Shimizu
AU  - Kazutoshi Tobimatsu
AU  - Shin Maeda
AU  - Makoto Ueno
PY  - 2026
JO  - BMC Cancer
DO  - 10.1186/s12885-026-15699-8
UR  - https://doi.org/10.1186/s12885-026-15699-8
ER  -

APA

Sano, Y., Kajikawa, R., Mizusawa, J., Ioka, T., Ozaka, M., Nakamura, S., Ito, Y., Furuse, J., Kobayashi, S., Fukuda, H., Okusaka, T., Ikeda, M., Miwa, H., Sasahira, N., Nagashima, F., Ohkawa, K., Yamazaki, K., Kanai, M., Yamashita, T., Hara, K., Takayama, Y., Komatsu, Y., Fujimori, N., Hama, N., Kamata, K., Hisano, T., Shimizu, S., Tobimatsu, K., Maeda, S., & Ueno, M. (2026). Comparison of chemoradiotherapy and gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer: an integrated analysis of two randomized phase II trials (JCOG2408A). BMC Cancer. https://doi.org/10.1186/s12885-026-15699-8

Source records

crossref · retrieved 2026-09-26T15:43:31.596Z